Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The cytokine interleukin (IL) 25 has been implicated in the initiation of type 2 immunity by driving the expression of type 2 cytokines such as IL-5 and IL-13, although its role in the regulation of immunity and infection-induced inflammation is unknown. Here, we identify a dual function for IL-25: first, in promoting type 2 cytokine-dependent immunity to gastrointestinal helminth infection and, second, in limiting proinflammatory cytokine production and chronic intestinal inflammation. Treatment of genetically susceptible mice with exogenous IL-25 promoted type 2 cytokine responses and immunity to Trichuris. IL-25 was constitutively expressed by CD4+ and CD8+ T cells in the gut of mouse strains that are resistant to Trichuris, and IL-25-deficient mice on a genetically resistant background failed to develop a type 2 immune response or eradicate infection. Furthermore, chronically infected IL-25(-/-) mice developed severe infection-induced intestinal inflammation associated with heightened expression of interferon-gamma and IL-17, identifying a role for IL-25 in limiting pathologic inflammation at mucosal sites. Therefore, IL-25 is not only a critical mediator of type 2 immunity, but is also required for the regulation of inflammation in the gastrointestinal tract.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early studies showed that IL-25 gene expression was elevated following Aspergillus and Nippostrongylus infection in the lung and gut, and that IL-25 promoted epithelial cell hyperplasia, increased mucus secretion, and airway hyperreactivity”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Owyang et al., 2006
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099 · cited 1×
“Recent studies have shown that IL-17–producing CD4+ T cells mediate chronic infl ammation in the central nervous system of animals that develop experimental autoimmune encephalitis (EAE), an animal model of multiple sclerosis that is characterized by chronic infl ammatory responses and demyelination of neurons (28, 29…”
Self-citationInterleukin-12 and the regulation of innate resistance and adaptive immunity
Trinchieri, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1001 · Cited by 3,927
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906 · cited 1×
“Recent studies have shown that IL-17–producing CD4+ T cells mediate chronic infl ammation in the central nervous system of animals that develop experimental autoimmune encephalitis (EAE), an animal model of multiple sclerosis that is characterized by chronic infl ammatory responses and demyelination of neurons (28, 29…”
Self-citationInterleukin-17 Family Members and Inflammation
Kolls, J. K., & Lindén, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.08.018 · Cited by 2,372
Increased expression of interleukin 17 in inflammatory bowel disease
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T., & Fujiyama, Y. (2003) · Gut · doi:10.1136/gut.52.1.65 · Cited by 1,713
The lineage decisions of helper T cells
Murphy, K. M., & Reiner, S. L. (2002) · Nature Reviews Immunology · doi:10.1038/nri954 · Cited by 1,674
IL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo
Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00243-6 · Cited by 1,203
Interleukin-17 family and IL-17 receptors
Moseley, T. A., Haudenschild, D. R., Rose, L., & Reddi, A. H. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00002-9 · Cited by 918
Mast-cell responses to pathogens
Marshall, J. S. (2004) · Nature Reviews Immunology · doi:10.1038/nri1460 · Cited by 861
A sthma : Mechanisms of Disease Persistence and Progression
Cohn, L., Elias, J. A., & Chupp, G. L. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104716 · Cited by 812
Hurst, S. D., Muchamuel, T., Gorman, D. M., Gilbert, J. M., Clifford, T., Kwan, S., Menon, S., Seymour, B., Jackson, C., Kung, T. T., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.1.443 · Cited by 619
Asthma: an epidemic of dysregulated immunity
Umetsu, D. T., McIntire, J. J., Akbari, O., Macaubas, C., & DeKruyff, R. H. (2002) · Nature Immunology · doi:10.1038/ni0802-715 · Cited by 599
Cytokine-mediated regulation of chronic intestinal helminth infection.
Else, K. J., Finkelman, F. D., Maliszewski, C. R., & Grencis, R. K. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.1.347 · Cited by 422
IL-17E, a Novel Proinflammatory Ligand for the IL-17 Receptor Homolog IL-17Rh1
Lee, J., Ho, W.-H., Maruoka, M., Corpuz, R. T., Baldwin, D. T., Foster, J. S., Goddard, A. D., Yansura, D. G., Vandlen, R. L., Wood, W. I., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008289200 · Cited by 405
Kawaguchi, M., Adachi, M., Oda, N., Kokubu, F., & Huang, S.-K. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.10.019 · Cited by 336
RELMβ/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract
Artis, D., Wang, M. L., Keilbaugh, S. A., He, W., Brenes, M., Swain, G. P., Knight, P. A., Donaldson, D. D., Lazar, M. A., Miller, H. R. P., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404034101 · Cited by 326
Self-citationA Critical Role for IL-13 in Resistance to Intestinal Nematode Infection
Bancroft, A. J., McKenzie, A. N. J., & Grencis, R. K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.7.3453 · Cited by 287
Signaling pathways in Th2 development
Mowen, K. A., & Glimcher, L. H. (2004) · Immunological Reviews · doi:10.1111/j.0105-2896.2004.00209.x · Cited by 255
The IL-27 Receptor (WSX-1) Is an Inhibitor of Innate and Adaptive Elements of Type 2 Immunity
Artis, D., Villarino, A., Silverman, M., He, W., Thornton, E. M., Mu, S., Summer, S., Covey, T. M., Huang, E., Yoshida, H., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.9.5626 · Cited by 245
Self-citationMast cells produce interleukin-25 upon FcεRI-mediated activation
Ikeda, K., Nakajima, H., Suzuki, K., Kagami, S.-I., Hirose, K., Suto, A., Saito, Y., & Iwamoto, I. (2003) · Blood · doi:10.1182/blood-2002-09-2817 · Cited by 240
IL-10 Is Critical for Host Resistance and Survival During Gastrointestinal Helminth Infection
Schopf, L. R., Hoffmann, K. F., Cheever, A. W., Urban, J. F., & Wynn, T. A. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2383 · Cited by 210
Cliffe, L. J., & Grencis, R. K. (2004) · Advances in Parasitology · doi:10.1016/s0065-308x(04)57004-5 · Cited by 168
Artis, D., Humphreys, N. E., Bancroft, A. J., Rothwell, N. J., Potten, C. S., & Grencis, R. K. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.953 · Cited by 147
Self-citationAltered expression of interferon-γ and interleukin-4 in inflammatory bowel disease
Camoglio, L., Te Velde, A. A., Tigges, A. J., Das, P. K., & Van Deventer, S. J. H. (1998) · Inflammatory Bowel Diseases · doi:10.1002/ibd.3780040406 · Cited by 132
Artis, D., Shapira, S., Mason, N., Speirs, K. M., Goldschmidt, M., Caamaño, J., Liou, H.-C., Hunter, C. A., & Scott, P. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.8.4481 · Cited by 80
Self-citationScudamore, C. L., McMillan, L., Thornton, E. M., Wright, S. H., Newlands, G. F. J., & Miller, H. R. P. (1997) · Europe PMC (PubMed Central) · Cited by 72
Self-citationInterleukin 1 plays a major role in the development of Th2‐mediated immunity
Helmby, H., & Grencis, R. K. (2004) · European Journal of Immunology · doi:10.1002/eji.200425452 · Cited by 72
The Receptor for Interleukin‐17E is Induced by Th2 Cytokines in Antigen‐Presenting Cells
Gratchev, A., Kzhyshkowska, J., Duperrier, K., Utikal, J., Velten, F. W., & Goerdt, S. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01443.x · Cited by 59
Th2 Cells: Orchestrating Barrier Immunity
(2004) · Advances in Immunology · doi:10.1016/s0065-2776(04)83005-0 · Cited by 44
Epstein-Barr virus-dependent lymphoproliferative disease: critical role of IL-6
(2000) · Pure Amsterdam UMC · doi:10.1002/1521-4141(200007)30:7 · Cited by 1
Self-citation
Cited by
IL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842
“In an effort to identify the cellular source of IL25, an IL-25-lacZ knock-in reporter system was developed, with which CD4+ and CD8+ T cells were identified in the cecal patch (analog of the human appendix) (126).”
BackgroundMethodHelminth infections: the great neglected tropical diseases
Hotez, P. J., Brindley, P. J., Bethony, J. M., King, C. H., Pearce, E. J., & Jacobson, J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34261 · Cited by 1,568
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“Early studies showed that IL-25 gene expression was elevated following Aspergillus and Nippostrongylus infection in the lung and gut, and that IL-25 promoted epithelial cell hyperplasia, increased mucus secretion, and airway hyperreactivity (Owyang et al., 2006).”
BackgroundSelf-citationFunctional Specialization of Interleukin-17 Family Members
Iwakura, Y., Ishigame, H., Saijo, S., & Nakae, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.012 · Cited by 1,289
Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit
von Moltke, J., Ji, M., Liang, H.-E., & Locksley, R. M. (2016) · Nature · doi:10.1038/nature16161 · Cited by 1,230
Metadata
- Authors
- Owyang, A. M., Zaph, C., Wilson, E. H., Guild, K. J., McClanahan, T., Miller, H. R. P., Cua, D. J., Goldschmidt, M., Hunter, C. A., Kastelein, R. A., & Artis, D.
- Affiliations
- 2Discovery Research, Schering-Plough Biopharma, Palo Alto, CA 94304
- University of Pennsylvania (US)
- University of Edinburgh (GB)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-04-10
- Volume
- 203
- Issue
- 4
- Pages
- 843-849
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC1800834
- OpenAlex
- W2158591788
- Cited by
- 379
- References
- 30
- Citations by year
- 2026: 4 · 2025: 11 · 2024: 8 · 2023: 17 · 2022: 24 · 2021: 14 · 2020: 15 · 2019: 12 · 2018: 17 · 2017: 18 · 2016: 20 · 2015: 20 · 2014: 26 · 2013: 24 · 2012: 19
- FWCI
- 9.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (AI 42334, R01AI042334, R01AI061570, AI 61570)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-50306, P30DK050306)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-25, Th2 immune response, type 2 cytokines, IL-5, IL-13, gastrointestinal helminth infection, Trichuris, chronic intestinal inflammation, interferon-gamma, IL-17, mucosal immunity, CD4+ T cells, CD8+ T cells, genetic susceptibility to infection
- MeSH terms
- Animals, Cell Differentiation, Cells, Cultured, Chronic Disease, Inflammation, Interleukins, Mice, Inbred AKR, Mice, Inbred C57BL, Recombinant Proteins, Trichuriasis, Trichuris, Cytokines, Mice, SCID, Mice, Knockout, Th1 Cells, Gastrointestinal Tract, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.